Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 352† | 410† | 387† | 366† | 401† |
| Net profit | -14 | 24 | 25 | 43 | 62† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Reena Sachin Patel | Alternate Director | June 30, 2026 |
| Dinesh Shantilal Patel | Executive Director | June 30, 2026 |
| Sachin Dinesh Patel | Executive Director | June 30, 2026 |
| Bhaskar Vemban Iyer | Independent Director | June 30, 2026 |
| Neha Anant Thakore | Independent Director | June 30, 2026 |
| Nikunt Kirit Raval | Independent Director | June 30, 2026 |
| Shishir Vasant Dalal | Independent Director | June 30, 2026 |
| Adam Demeter | Non-Executive Director | June 30, 2026 |
| Rajneesh Kedarnath Anand | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
